store at low temperature
store at -80°C
Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist. Feladilimab binds to ICOS-expressing T cells, induces IFNγ, and increases PD-1/L1 expression. Feladilimab has anti-tumor activity and can be used to study cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 247.00 | |
5 mg | In stock | $ 647.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,530.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,780.00 |
Description | Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist. Feladilimab binds to ICOS-expressing T cells, induces IFNγ, and increases PD-1/L1 expression. Feladilimab has anti-tumor activity and can be used to study cancer. |
Synonyms | GSK3359609 |
Molecular Weight | N/A |
CAS No. | 2252518-85-5 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Feladilimab 2252518-85-5 Apoptosis Cell Cycle/Checkpoint Immunology/Inflammation Neuroscience COX PD-1/PD-L1 GSK 3359609 GSK3359609 GSK-3359609 inhibitor inhibit